Search - tctmd.com

Displaying 421 - 440 of 1183

Sort: Relevancy | Date

Presentation TCT 2021

Treating the Lymphatic System for Acute and Chronic HF

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

New Approaches to Diuresis - Reprieve

Presenter: Jeffrey Testani

November 06, 2021

Presentation TCT 2021

Manipulation of Renal Preload and Afterload for Acute Decompensated Heart Failure

Presenter: Navin Kapur

November 06, 2021

Presentation TCT 2021

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Presenter: W. H. Wilson Tang

November 06, 2021

Presentation TCT 2021

AXON Therapeutics

Presenter: Sanjiv Shah

November 06, 2021

Presentation TCT 2021

CVRx - Barostimulation -- CVRx and LivaNova

Presenter: Michael R. Zile

November 06, 2021

Presentation TCT 2021

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

Presenter: Daniel Burkhoff

November 06, 2021

Presentation TCT 2021

LV Reconstruction II: Bioventrix

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2021

LV Reconstruction I: Ancora

Presenter: Nadira Hamid

November 06, 2021

Presentation TCT 2021

Overview of Devices for HF: Current and Future Prospects

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

A Validation Study of the OpSens LV Pressure Guidewire

Presenter: Philippe Genereux

November 05, 2021

Presentation TCT 2021

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Presenter: Daniel Burkhoff

November 05, 2021

Presentation TCT 2021

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Presenter: William C. Altman

November 05, 2021

Presentation TCT 2021

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Presenter: Harlee Sorkin

November 05, 2021

Presentation TCT 2021

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Presenter: Jacob Kriegel

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

Presenter: William Abraham

November 05, 2021

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

Presentation TCT 2021

Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Presenter: Stephan Milhorini Pio

November 04, 2021

Advertisement

Treating the Lymphatic System for Acute and Chronic HF

New Approaches to Diuresis - Reprieve

Manipulation of Renal Preload and Afterload for Acute Decompensated Heart Failure

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

AXON Therapeutics

CVRx - Barostimulation -- CVRx and LivaNova

Interatrial Shunts: Physiological Rationale and Hemodynamic Effects

LV Reconstruction II: Bioventrix

LV Reconstruction I: Ancora

Overview of Devices for HF: Current and Future Prospects

A Validation Study of the OpSens LV Pressure Guidewire

Cardiac Neuromodulation Therapy Effect on Systolic Blood Pressure and Pulse Pressure in Patients with Isolated Systolic Hypertension In A Randomized Double-Blind Study Together With Long Term Follow Up Results (Backbeat Medical)

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Implant-less Percutaneous Atrial Shunt-Catheter (PAS-C) System: InterShunt

Alleviant System: Implant-Free Interatrial Shunt Creation for Heart Failure

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content